Mobile phone users will be paid for their old and unwanted handsets as part of an innovative New Zealand-first mobile phone recycling and recovery scheme.
Valensa International (Eustis, FL USA) announced the introduction of a new eye health formulation that combines the leading eye health ingredients in a single, easy-to-use product. Called Eye Pro MD, the new formulation contains carotenoids astaxanthin, lutein, and zeaxanthin and features a...
The University of Bath has received funding from the International Rugby Board to launch a major study of the scrum that will that drive best practice player welfare policy in this critical area of the game. The two-year study the Biomechanics of the Rugby Scrum will provide an in-depth analysis...
The 0.facebook.com website is lightweight and optimised for speed on mobile devices. Data charges do not apply for the site, which is available on WAP browsers.
The company is clearly placing bets on enticing iPhone users who signed up for two year contracts back in July 2008 when Vodafone launched the first of these devices in the country, and will soon be free to port their numbers to other mobile networks if they feel so inclined - and if they see...
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and European launches of the Sterling® SL PTA Balloon Dilatation Catheter, a high-performance balloon dilatation catheter designed for use in peripheral angioplasty procedures below the knee. The Company plans to launch the...
B. Braun Medical is both an exhibitor at and proud sponsor of the 20th Congress of the European Wound Management Association (EWMA) in Geneva, Switzerland (May 26th-28th, 2010), which is dedicated to finding solutions to the wound care puzzle. B. Braun launches its 3-in-1 technology foam...
Teleflex Medical has announced the introduction of a comprehensive education program in respiratory therapy, designed to provide an in-depth curriculum focused on maximizing humidification and minimizing challenges through the therapeutic levels outlined in the Respiratory Pyramid of Care. The...
An outbreak of E. coli O145 in three states has hospitalized 12, three of whom have developed hemolytic Uremic syndrome (HUS), a severe complication of E. coli infection. Victims in Michigan, Ohio, and New York are ill with E. coli O145, which has been linked to a recall of tainted lettuce by...
ReadyCloud Server provides a hosted ICT environment that enables the deployment of highly available, cost effective and agile computing. It forms part of Gen-i's new ReadyCloud Services. Two other offerings, ReadyCloud Backup and ReadyCloud Storage, are in development and will launch later this...
The American Medical Group Association (AMGA) announced that it will launch two collaborative focused on practical steps toward creating high-performing organizations and systems of care termed Accountable Care Organizations: a Development Collaborative and an Implementation Collaborative...
IntegraMed America, Inc. (NASDAQ: INMD), the leader in developing and managing specialty healthcare networks in fertility and vein care, launched web portal AttainFertility.com, a new destination site offering comprehensive fertility information. AttainFertility.com is an interactive web...
Hospital for Special Care announced the launch of the region's first Amyotrophic Lateral Sclerosis (ALS) Clinical Trials Unit at its Neuromuscular Center. The new unit will be headed by Jinsy A. Andrews, M.D., a physician researcher recruited from Columbia University. Dr. Andrews, Director of...
Gentel Biosciences, a leader in proteomics discovery tools, today announced the availability of the APiX View™ Detection Kits for ultra-sensitive chromogenic detection of protein microarrays, including reverse phase protein such as SomaPlex™ arrays from Protein Biotechnologies. Alex Vodenlich...
Serametrix has announced the commercial launch of a serum test for measuring serum antibodies to the important tumor antigen NY-ESO-1. The test will be offered as a service to drug companies and clinicians for correlative studies, monitoring and potentially predicting patient responses to cancer...
Serametrix has announced the commercial launch of a serum test for measuring serum antibodies to the important tumor antigen NY-ESO-1. The test will be offered as a service to drug companies and clinicians for correlative studies, monitoring and potentially predicting patient responses to cancer...
Serametrix has announced the commercial launch of a serum test for measuring serum antibodies to the important tumor antigen NY-ESO-1. The test will be offered as a service to drug companies and clinicians for correlative studies, monitoring and potentially predicting patient responses to cancer...